BRIEF-4D Molecular Therapeutics Q3 Net Income USD -56.876 Million Vs. IBES Estimate USD -56.2 Million

Reuters
Nov 10
BRIEF-<a href="https://laohu8.com/S/FDMT">4D Molecular Therapeutics</a> Q3 Net Income USD -56.876 Million Vs. IBES Estimate USD -56.2 Million

Nov 10 (Reuters) - 4D Molecular Therapeutics Q3 basic EPS USD -1.01.

  • Q3 operating income USD -61.185 million vs. IBES estimate USD -61.6 million
  • Q3 revenue USD 90 thousand vs. IBES estimate USD 287.9 thousand
  • Q3 operating expenses USD 61.275 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10